Mycosis fungoides: review of epidemiological observations
- PMID: 10971054
- DOI: 10.1159/000018423
Mycosis fungoides: review of epidemiological observations
Abstract
Background: Mycosis fungoides (MF) is a chronic cutaneous T-cell lymphoma characterized by small cells with cerebriform nuclei that usually express a mature peripheral T-helper cell (CD4+) immunophenotype. Its evolution is typically quite slow, with years between the first manifestations and development of advanced stages of disease.
Objective: The purpose of the present paper is to contribute to the material about MF already present in the literature. The review articles that have appeared to date fundamentally address the morphological characteristics, diagnostic criteria and treatment of the disease; in contrast, the present study centers on the evolution of the incidence of MF and on the knowledge of the possible risk factors implicated in its development.
Methods: Review of published papers about MF epidemiology.
Results: The evidence suggests that the incidence is increasing, but this may be artifactual due to improved diagnostic techniques. The risk of MF is limited to gender and race, being higher in males and in blacks. Survival is highly stage dependent, but 90% of patients survive 15 years with only 10% of cutaneous involvement. Few risk factors have been identified, but several studies have found an association with industrial exposure, particularly to oils.
Conclusion: MF is a rare disease and its risk factors have not been studied in any great detail. A European case-control study in progress will substantially increase the evidence available and progress towards identifying a prevention strategy.
Copyright 2000 S. Karger AG, Basel.
Similar articles
-
Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.J Am Acad Dermatol. 2014 Jun;70(6):993-1001. doi: 10.1016/j.jaad.2013.12.029. Epub 2014 Mar 12. J Am Acad Dermatol. 2014. PMID: 24629999
-
Occupational mycosis fungoides - a case series.Int J Dermatol. 2017 Jul;56(7):733-737. doi: 10.1111/ijd.13589. Epub 2017 Mar 3. Int J Dermatol. 2017. PMID: 28255994
-
Epidemiology of mycosis fungoides.Semin Dermatol. 1994 Sep;13(3):154-9. Semin Dermatol. 1994. PMID: 7986682
-
Cutaneous lymphomas and association to sex hormones.Skinmed. 2003 Sep-Oct;2(5):312-5. doi: 10.1111/j.1540-9740.2003.02629.x. Skinmed. 2003. PMID: 14673266 Review.
-
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. J Am Acad Dermatol. 2014. PMID: 24438969 Review.
Cited by
-
Dorsal Hand and Foot Mycosis Fungoides: Looking Beyond Mycosis Fungoides Palmaris et Plantaris.Acta Derm Venereol. 2022 Sep 28;102:adv00783. doi: 10.2340/actadv.v102.2557. Acta Derm Venereol. 2022. PMID: 36129248 Free PMC article. No abstract available.
-
T-small cell disorders.Curr Treat Options Oncol. 2001 Jun;2(3):225-35. doi: 10.1007/s11864-001-0036-2. Curr Treat Options Oncol. 2001. PMID: 12057122 Review.
-
Disseminated mature T-cell phenotype CD4/CD8 double-negative mycosis fungoides with pleural involvement.Hematol Transfus Cell Ther. 2022 Oct-Dec;44(4):606-611. doi: 10.1016/j.htct.2021.07.004. Epub 2021 Sep 20. Hematol Transfus Cell Ther. 2022. PMID: 34593365 Free PMC article. No abstract available.
-
Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure.Oncologist. 2021 Sep;26(9):727-e1488. doi: 10.1002/onco.13785. Epub 2021 May 14. Oncologist. 2021. PMID: 33851477 Free PMC article. Clinical Trial.
-
Mycosis fungoides: is it a Borrelia burgdorferi-associated disease?Br J Cancer. 2006 Mar 27;94(6):879-83. doi: 10.1038/sj.bjc.6602997. Br J Cancer. 2006. PMID: 16495924 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials